CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 204580525
- Phone
- 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
Page 2 of 41 · 811 filings